Diseases & Conditions market research reports by GlobalData

• Resistant Hypertension (RH) - Competitive Landscape

  Apr 05, 2024  |  Published by: GlobalData  |  USD 3,495

  Resistant Hypertension (RH) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RH therapeutics. GlobalData epidemiologists estimated more than 79 million diagnosed prevalent cases of RH in 2023 in the 16 countries covered i ... Read More

• Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023

  Mar 27, 2024  |  Published by: GlobalData  |  USD 695

  Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023 Summary This report provides an overview of global clinical trials with a start date between January 1, 2023, and December 31, 2023. Scope The clinical trials data used for these analyses were extracted from GlobalData’s Clinical ... Read More

• Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 provides an overview of Arthralgia (Joint Pain) Clinical trials scenario. This report provides top line data relating to the clinic ... Read More

• Augmented Reality in Healthcare - Thematic Research

  Mar 22, 2024  |  Published by: GlobalData  |  USD 995

  Augmented Reality in Healthcare - Thematic Research Summary Augmented reality (AR) is a technology that allows the user to see the real world overlaid with digital data. According to GlobalData forecasts, the AR market will be worth $100 billion by 2030, up from $22 billion in 2022. Rather than enab ... Read More

• Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success

  Mar 19, 2024  |  Published by: GlobalData  |  USD 495

  Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success Summary This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements ... Read More

• Online Travel - Thematic Research

  Mar 08, 2024  |  Published by: GlobalData  |  USD 995

  Online Travel - Thematic Research Summary This thematic research report takes an in-depth look at the theme of online travel and the impact it has on the travel and tourism industry. This report analyzes the players impacted by this theme alongside the contributing trends, negative destination trend ... Read More

• Cell and Gene Therapies in Hemophilia A & B

  Feb 29, 2024  |  Published by: GlobalData  |  USD 9,995

  Cell and Gene Therapies in Hemophilia A & B Summary Clients will gain insight into the competitive landscape of leading CGT agents in Hemophilia A & B including launch date projections, key clinical trial analysis, analyst consensus forecasts, likelihood of approval analysis, and commentary on curre ... Read More

• Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Feb 27, 2024  |  Published by: GlobalData  |  USD 4,000

  Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of D ... Read More

• Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 provide ... Read More

• Lupus Nephritis - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Lupus Nephritis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Lupus Nephritis - Global Clinical Trials Review, 2024 provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephr ... Read More

• Ewing Sarcoma - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Ewing Sarcoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2024 provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Re ... Read More

• Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This r ... Read More

• Seasonal Influenza - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Seasonal Influenza - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Seasonal Influenza - Global Clinical Trials Review, 2024 provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Se ... Read More

• Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report pro ... Read More

• Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032

  Feb 16, 2024  |  Published by: GlobalData  |  USD 3,995

  Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032 Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases (National Cancer Institute, 2020). NSCLC begins when healthy cells that make up the lining of ... Read More

• Ovarian Cancer Opportunity Assessment and Forecast

  Feb 08, 2024  |  Published by: GlobalData  |  USD 9,995

  Ovarian Cancer Opportunity Assessment and Forecast Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Ovarian Cancer. These sales fo ... Read More

• Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

  Jan 31, 2024  |  Published by: GlobalData  |  USD 7,500

  Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize qu ... Read More

• Digital Marketing Trends in Psoriasis - January 2024

  Jan 30, 2024  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Psoriasis - January 2024 Summary AbbVie’s Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US, with almost three million visitors from January 2023 to December 2023. This was followed by Amgen’s Otezla.com (1.7 million visits). Overal ... Read More

• Malaria - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Malaria - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Malaria - Global Clinical Trials Review, 2024 provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overvie ... Read More

• Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 provides an overview of Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top line data relating to the clinic ... Read More

• Thematic Intelligence - Biosimilars in oncology

  Dec 29, 2023  |  Published by: GlobalData  |  USD 7,995

  Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More

• Gout - Opportunity Assessment and Forecast

  Dec 22, 2023  |  Published by: GlobalData  |  USD 9,995

  Gout - Opportunity Assessment and Forecast Summary The prevalence of gout is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 1.18%. Currently, the treatment regimen for gout in the 7MM is mostly limited to NSAIDs, corticosteroids, and ULTs with challenging safety ... Read More

• Hepatitis B - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Hepatitis B - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatitis B Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data ... Read More

• Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More

• Gallbladder Cancer - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >